{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T22:28:01Z","timestamp":1783636081755,"version":"3.55.0"},"reference-count":52,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T00:00:00Z","timestamp":1463443200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 AR052658"],"award-info":[{"award-number":["R01 AR052658"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arthritis Res Ther"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s13075-016-1009-y","type":"journal-article","created":{"date-parts":[[2016,5,17]],"date-time":"2016-05-17T03:55:21Z","timestamp":1463457321000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Differential response of serum amyloid A to different therapies in early rheumatoid arthritis and its potential value as a disease activity biomarker"],"prefix":"10.1186","volume":"18","author":[{"given":"Yong Gil","family":"Hwang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goundappa K.","family":"Balasubramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilinca D.","family":"Metes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc C.","family":"Levesque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"S. Louis","family":"Bridges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry W.","family":"Moreland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,5,17]]},"reference":[{"issue":"6","key":"1009_CR1","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1002\/art.1780300603","volume":"30","author":"PW Thompson","year":"1987","unstructured":"Thompson PW, Silman AJ, Kirwan JR, Currey HL. Articular indices of joint inflammation in rheumatoid arthritis. Correlation with the acute-phase response. Arthritis Rheum. 1987;30(6):618\u201323.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1009_CR2","first-page":"9","volume":"24","author":"J Devlin","year":"1997","unstructured":"Devlin J, Gough A, Huissoon A, Perkins P, Holder R, Reece R, et al. The acute phase and function in early rheumatoid arthritis. C-reactive protein levels correlate with functional outcome. J Rheumatol. 1997;24(1):9\u201313.","journal-title":"J Rheumatol"},{"issue":"Suppl 3","key":"1009_CR3","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1093\/rheumatology\/32.suppl_3.9","volume":"32","author":"MA van Leeuwen","year":"1993","unstructured":"van Leeuwen MA, van Rijswijk MH, van der Heijde DM, Te Meerman GJ, van Riel PL, Houtman PM, et al. The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: a prospective study during the first three years of the disease. Br J Rheumatol. 1993;32 Suppl 3:9\u201313.","journal-title":"Br J Rheumatol."},{"issue":"3","key":"1009_CR4","first-page":"425","volume":"21","author":"MA van Leeuwen","year":"1994","unstructured":"van Leeuwen MA, van der Heijde DM, van Rijswijk MH, Houtman PM, van Riel PL, van de Putte LB, et al. Interrelationship of outcome measures and process variables in early rheumatoid arthritis. A comparison of radiologic damage, physical disability, joint counts, and acute phase reactants. J Rheumatol. 1994;21(3):425\u20139.","journal-title":"J Rheumatol"},{"issue":"1","key":"1009_CR5","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1002\/art.1780380107","volume":"38","author":"ML Prevoo","year":"1995","unstructured":"Prevoo ML, MA v \u2018t, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38(1):44\u20138.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1009_CR6","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1002\/art.1780390105","volume":"39","author":"AM van Gestel","year":"1996","unstructured":"van Gestel AM, Prevoo ML, Hof MA v \u2018t, van Rijswijk MH, van de Putte LB, van Riel PL. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization\/International League Against Rheumatism Criteria. Arthritis Rheum. 1996;39(1):34\u201340.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1009_CR7","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1080\/10245330701340734","volume":"12","author":"A Osei-Bimpong","year":"2007","unstructured":"Osei-Bimpong A, Meek JH, Lewis SM. ESR or CRP? A comparison of their clinical utility. Hematology. 2007;12(4):353\u20137.","journal-title":"Hematology"},{"key":"1009_CR8","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1186\/1471-2474-15-368","volume":"15","author":"L Siemons","year":"2014","unstructured":"Siemons L, Ten Klooster PM, Vonkeman HE, van Riel PL, Glas CA, van de Laar MA. How age and sex affect the erythrocyte sedimentation rate and C-reactive protein in early rheumatoid arthritis. BMC Musculoskelet Disord. 2014;15:368.","journal-title":"BMC Musculoskelet Disord."},{"issue":"6","key":"1009_CR9","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1136\/ard.2007.084459","volume":"68","author":"G Wells","year":"2009","unstructured":"Wells G, Becker JC, Teng J, Dougados M, Schiff M, Smolen J, et al. Validation of the 28-joint Disease Activity Score (DAS28) and European League Against Rheumatism response criteria based on C-reactive protein against disease progression in patients with rheumatoid arthritis, and comparison with the DAS28 based on erythrocyte sedimentation rate. Ann Rheum Dis. 2009;68(6):954\u201360.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1009_CR10","doi-asserted-by":"publisher","first-page":"1387","DOI":"10.3899\/jrheum.080770","volume":"36","author":"T Sokka","year":"2009","unstructured":"Sokka T, Pincus T. Erythrocyte sedimentation rate, C-reactive protein, or rheumatoid factor are normal at presentation in 35 %-45% of patients with rheumatoid arthritis seen between 1980 and 2004: analyses from Finland and the United States. J Rheumatol. 2009;36(7):1387\u201390.","journal-title":"J Rheumatol"},{"issue":"5 Suppl 85","key":"1009_CR11","first-page":"S-23","volume":"32","author":"T Pincus","year":"2014","unstructured":"Pincus T, Gibson KA, Shmerling RH. An evidence-based approach to laboratory tests in usual care of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2014;32(5 Suppl 85):S-23\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"1009_CR12","first-page":"1227","volume":"21","author":"F Wolfe","year":"1994","unstructured":"Wolfe F, Michaud K. The clinical and research significance of the erythrocyte sedimentation rate. J Rheumatol. 1994;21(7):1227\u201337.","journal-title":"J Rheumatol"},{"issue":"2","key":"1009_CR13","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.amjmed.2005.06.057","volume":"119","author":"I Kushner","year":"2006","unstructured":"Kushner I, Rzewnicki D, Samols D. What does minor elevation of C-reactive protein signify? Am J Med. 2006;119(2):166. e117-128.","journal-title":"Am J Med"},{"issue":"9","key":"1009_CR14","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1136\/ard.2006.063834","volume":"66","author":"T Matsui","year":"2007","unstructured":"Matsui T, Kuga Y, Kaneko A, Nishino J, Eto Y, Chiba N, et al. Disease Activity Score 28 (DAS28) using C-reactive protein underestimates disease activity and overestimates EULAR response criteria compared with DAS28 using erythrocyte sedimentation rate in a large observational cohort of rheumatoid arthritis patients in Japan. Ann Rheum Dis. 2007;66(9):1221\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"1009_CR15","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1136\/ard.2006.054205","volume":"66","author":"E Inoue","year":"2007","unstructured":"Inoue E, Yamanaka H, Hara M, Tomatsu T, Kamatani N. Comparison of Disease Activity Score (DAS)28- erythrocyte sedimentation rate and DAS28- C-reactive protein threshold values. Ann Rheum Dis. 2007;66(3):407\u20139.","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"1009_CR16","doi-asserted-by":"publisher","first-page":"1296","DOI":"10.1136\/ard.2010.142240","volume":"70","author":"M Connolly","year":"2011","unstructured":"Connolly M, Veale DJ, Fearon U. Acute serum amyloid A regulates cytoskeletal rearrangement, cell matrix interactions and promotes cell migration in rheumatoid arthritis. Ann Rheum Dis. 2011;70(7):1296\u2013303.","journal-title":"Ann Rheum Dis"},{"issue":"2","key":"1009_CR17","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1253\/circj.71.186","volume":"71","author":"M Kosuge","year":"2007","unstructured":"Kosuge M, Ebina T, Ishikawa T, Hibi K, Tsukahara K, Okuda J, et al. Serum amyloid A is a better predictor of clinical outcomes than C-reactive protein in non-ST-segment elevation acute coronary syndromes. Circ J. 2007;71(2):186\u201390.","journal-title":"Circ J"},{"issue":"2","key":"1009_CR18","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1620\/tjem.219.121","volume":"219","author":"S Simic-Ogrizovic","year":"2009","unstructured":"Simic-Ogrizovic S, Dopsaj V, Bogavac-Stanojevic N, Obradovic I, Stosovic M, Radovic M. Serum amyloid-A rather than C-reactive protein is a better predictor of mortality in hemodialysis patients. Tohoku J Exp Med. 2009;219(2):121\u20137.","journal-title":"Tohoku J Exp Med"},{"issue":"2","key":"1009_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2168.2002.01972.x","volume":"89","author":"JM Mayer","year":"2002","unstructured":"Mayer JM, Raraty M, Slavin J, Kemppainen E, Fitzpatrick J, Hietaranta A, et al. Serum amyloid A is a better early predictor of severity than C-reactive protein in acute pancreatitis. Br J Surg. 2002;89(2):163\u201371.","journal-title":"Br J Surg"},{"issue":"8","key":"1009_CR20","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1097\/PAS.0b013e3181abdfa7","volume":"33","author":"H von Hutten","year":"2009","unstructured":"von Hutten H, Mihatsch M, Lobeck H, Rudolph B, Eriksson M, Rocken C. Prevalence and origin of amyloid in kidney biopsies. Am J Surg Pathol. 2009;33(8):1198\u2013205.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"1009_CR21","first-page":"58","volume":"27","author":"G Cunnane","year":"2000","unstructured":"Cunnane G, Grehan S, Geoghegan S, McCormack C, Shields D, Whitehead AS, et al. Serum amyloid A in the assessment of early inflammatory arthritis. J Rheumatol. 2000;27(1):58\u201363.","journal-title":"J Rheumatol"},{"issue":"7","key":"1009_CR22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.3899\/jrheum.080755","volume":"36","author":"S Visvanathan","year":"2009","unstructured":"Visvanathan S, Wagner C, Rojas J, Kay J, Dasgupta B, Matteson EL, et al. E-selectin, interleukin 18, serum amyloid a, and matrix metalloproteinase 9 are associated with clinical response to golimumab plus methotrexate in patients with active rheumatoid arthritis despite methotrexate therapy. J Rheumatol. 2009;36(7):1371\u20139.","journal-title":"J Rheumatol"},{"issue":"4","key":"1009_CR23","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1016\/S1734-1140(10)70329-7","volume":"62","author":"B Targonska-Stepniak","year":"2010","unstructured":"Targonska-Stepniak B, Dryglewska M, Majdan M. Influence of long-term leflunomide treatment on serum amyloid concentration in rheumatoid arthritis patients. Pharmacol Rep. 2010;62(4):719\u201325.","journal-title":"Pharmacol Rep"},{"key":"1009_CR24","doi-asserted-by":"publisher","first-page":"793628","DOI":"10.1155\/2014\/793628","volume":"2014","author":"B Targonska-Stepniak","year":"2014","unstructured":"Targonska-Stepniak B, Majdan M. Serum amyloid A as a marker of persistent inflammation and an indicator of cardiovascular and renal involvement in patients with rheumatoid arthritis. Mediators Inflamm. 2014;2014:793628.","journal-title":"Mediators Inflamm."},{"issue":"2","key":"1009_CR25","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.3892\/mmr.2014.2804","volume":"11","author":"C Shen","year":"2015","unstructured":"Shen C, Sun XG, Liu N, Mu Y, Hong CC, Wei W, et al. Increased serum amyloid A and its association with autoantibodies, acute phase reactants and disease activity in patients with rheumatoid arthritis. Mol Med Rep. 2015;11(2):1528\u201334.","journal-title":"Mol Med Rep"},{"issue":"9","key":"1009_CR26","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1002\/art.34498","volume":"64","author":"LW Moreland","year":"2012","unstructured":"Moreland LW, O'Dell JR, Paulus HE, Curtis JR, Bathon JM, St Clair EW, et al. A randomized comparative effectiveness study of oral triple therapy versus etanercept plus methotrexate in early aggressive rheumatoid arthritis: the treatment of Early Aggressive Rheumatoid Arthritis Trial. Arthritis Rheum. 2012;64(9):2824\u201335.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"1009_CR27","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1002\/art.1780310302","volume":"31","author":"FC Arnett","year":"1988","unstructured":"Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31(3):315\u201324.","journal-title":"Arthritis Rheum"},{"issue":"9","key":"1009_CR28","doi-asserted-by":"publisher","first-page":"2569","DOI":"10.1002\/art.27584","volume":"62","author":"D Aletaha","year":"2010","unstructured":"Aletaha D, Neogi T, Silman AJ, Funovits J, Felson DT, Bingham 3rd CO, et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative. Arthritis Rheumatol. 2010;62(9):2569\u201381.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"1009_CR29","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","volume":"107","author":"TA Pearson","year":"2003","unstructured":"Pearson TA, Mensah GA, Alexander RW, Anderson JL, Cannon 3rd RO, Criqui M, et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: A statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation. 2003;107(3):499\u2013511.","journal-title":"Circulation"},{"issue":"6","key":"1009_CR30","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.1002\/art.37916","volume":"65","author":"I Navarro-Millan","year":"2013","unstructured":"Navarro-Millan I, Charles-Schoeman C, Yang S, Bathon JM, Bridges Jr SL, Chen L, et al. Changes in lipoproteins associated with methotrexate or combination therapy in early rheumatoid arthritis: results from the treatment of early rheumatoid arthritis trial. Arthritis Rheum. 2013;65(6):1430\u20138.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"1009_CR31","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1128\/CDLI.10.4.652-657.2003","volume":"10","author":"N Aziz","year":"2003","unstructured":"Aziz N, Fahey JL, Detels R, Butch AW. Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clin Diagn Lab Immunol. 2003;10(4):652\u20137.","journal-title":"Clin Diagn Lab Immunol"},{"issue":"1-2","key":"1009_CR32","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0022-1759(98)00057-X","volume":"214","author":"S Poole","year":"1998","unstructured":"Poole S, Walker D, Gaines Das RE, Gallimore JR, Pepys MB. The first international standard for serum amyloid A protein (SAA). Evaluation in an international collaborative study. J Immunol Methods. 1998;214(1-2):1\u201310.","journal-title":"J Immunol Methods"},{"issue":"2","key":"1009_CR33","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1111\/cei.12234","volume":"175","author":"K Migita","year":"2014","unstructured":"Migita K, Izumi Y, Jiuchi Y, Kozuru H, Kawahara C, Izumi M, et al. Effects of Janus kinase inhibitor tofacitinib on circulating serum amyloid A and interleukin-6 during treatment for rheumatoid arthritis. Clin Exp Immunol. 2014;175(2):208\u201314.","journal-title":"Clin Exp Immunol"},{"issue":"2","key":"1009_CR34","first-page":"161","volume":"55","author":"MB Christensen","year":"2014","unstructured":"Christensen MB, Langhorn R, Goddard A, Andreasen EB, Moldal E, Tvarijonaviciute A, et al. Comparison of serum amyloid A and C-reactive protein as diagnostic markers of systemic inflammation in dogs. Can Vet J. 2014;55(2):161\u20138.","journal-title":"Can Vet J"},{"key":"1009_CR35","doi-asserted-by":"publisher","first-page":"183653","DOI":"10.1155\/2013\/183653","volume":"2013","author":"MM Ally","year":"2013","unstructured":"Ally MM, Hodkinson B, Meyer PW, Musenge E, Tikly M, Anderson R. Serum matrix metalloproteinase-3 in comparison with acute phase proteins as a marker of disease activity and radiographic damage in early rheumatoid arthritis. Mediators Inflamm. 2013;2013:183653.","journal-title":"Mediators Inflamm."},{"issue":"4","key":"1009_CR36","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1615\/CritRevImmunol.v32.i4.40","volume":"32","author":"KK Eklund","year":"2012","unstructured":"Eklund KK, Niemi K, Kovanen PT. Immune functions of serum amyloid A. Crit Rev Immunol. 2012;32(4):335\u201348.","journal-title":"Crit Rev Immunol"},{"key":"1009_CR37","doi-asserted-by":"crossref","unstructured":"Takata S, Wada H, Tamura M, Koide T, Higaki M, Mikura SI, Yasutake T, Hirao S, Nakamura M, Honda K et al. Kinetics of c-reactive protein (CRP) and serum amyloid A protein (SAA) in patients with community-acquired pneumonia (CAP), as presented with biologic half-life times. Biomarkers. 2011;16(6):530\u2013535.","DOI":"10.3109\/1354750X.2011.607189"},{"issue":"4","key":"1009_CR38","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.1002\/art.33455","volume":"64","author":"M Connolly","year":"2012","unstructured":"Connolly M, Mullan RH, McCormick J, Matthews C, Sullivan O, Kennedy A, et al. Acute-phase serum amyloid A regulates tumor necrosis factor alpha and matrix turnover and predicts disease progression in patients with inflammatory arthritis before and after biologic therapy. Arthritis Rheum. 2012;64(4):1035\u201345.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"1009_CR39","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2249.2010.04242.x","volume":"162","author":"K Migita","year":"2010","unstructured":"Migita K, Koga T, Torigoshi T, Motokawa S, Maeda Y, Jiuchi Y, et al. Induction of interleukin-23 p19 by serum amyloid A (SAA) in rheumatoid synoviocytes. Clin Exp Immunol. 2010;162(2):244\u201350.","journal-title":"Clin Exp Immunol"},{"issue":"1","key":"1009_CR40","doi-asserted-by":"publisher","first-page":"28","DOI":"10.3109\/s10165-012-0630-0","volume":"23","author":"K Satomura","year":"2013","unstructured":"Satomura K, Torigoshi T, Koga T, Maeda Y, Izumi Y, Jiuchi Y, et al. Serum amyloid A (SAA) induces pentraxin 3 (PTX3) production in rheumatoid synoviocytes. Mod Rheumatol. 2013;23(1):28\u201335.","journal-title":"Mod Rheumatol"},{"issue":"11","key":"1009_CR41","doi-asserted-by":"publisher","first-page":"6427","DOI":"10.4049\/jimmunol.0902941","volume":"184","author":"M Connolly","year":"2010","unstructured":"Connolly M, Marrelli A, Blades M, McCormick J, Maderna P, Godson C, et al. Acute serum amyloid A induces migration, angiogenesis, and inflammation in synovial cells in vitro and in a human rheumatoid arthritis\/SCID mouse chimera model. J Immunol. 2010;184(11):6427\u201337.","journal-title":"J Immunol"},{"issue":"7","key":"1009_CR42","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/rheumatology\/kep089","volume":"48","author":"K Migita","year":"2009","unstructured":"Migita K, Koga T, Torigoshi T, Maeda Y, Miyashita T, Izumi Y, et al. Serum amyloid A protein stimulates CCL20 production in rheumatoid synoviocytes. Rheumatology (Oxford). 2009;48(7):741\u20137.","journal-title":"Rheumatology (Oxford)"},{"key":"1009_CR43","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1111\/j.1749-6632.1995.tb32318.x","volume":"762","author":"I Kushner","year":"1995","unstructured":"Kushner I, Jiang SL, Zhang D, Lozanski G, Samols D. Do post-transcriptional mechanisms participate in induction of C-reactive protein and serum amyloid A by IL-6 and IL-1? Ann NY Acad Sci. 1995;762:102\u20137.","journal-title":"Ann NY Acad Sci."},{"key":"1009_CR44","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1186\/1471-2466-14-95","volume":"14","author":"C Calero","year":"2014","unstructured":"Calero C, Arellano E, Lopez-Villalobos JL, Sanchez-Lopez V, Moreno-Mata N, Lopez-Campos JL. Differential expression of C-reactive protein and serum amyloid A in different cell types in the lung tissue of chronic obstructive pulmonary disease patients. BMC Pulm Med. 2014;14:95.","journal-title":"BMC Pulm Med."},{"issue":"6","key":"1009_CR45","doi-asserted-by":"publisher","first-page":"e66769","DOI":"10.1371\/journal.pone.0066769","volume":"8","author":"D de Seny","year":"2013","unstructured":"de Seny D, Cobraiville G, Charlier E, Neuville S, Esser N, Malaise D, et al. Acute-phase serum amyloid a in osteoarthritis: regulatory mechanism and proinflammatory properties. PLoS One. 2013;8(6):e66769.","journal-title":"PLoS One"},{"issue":"8","key":"1009_CR46","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1093\/rheumatology\/keq117","volume":"49","author":"EM Hensor","year":"2010","unstructured":"Hensor EM, Emery P, Bingham SJ, Conaghan PG, Consortium Y. Discrepancies in categorizing rheumatoid arthritis patients by DAS-28(ESR) and DAS-28(CRP): can they be reduced? Rheumatology (Oxford). 2010;49(8):1521\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"6","key":"1009_CR47","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/art.27440","volume":"62","author":"L Bjorkman","year":"2010","unstructured":"Bjorkman L, Raynes JG, Shah C, Karlsson A, Dahlgren C, Bylund J. The proinflammatory activity of recombinant serum amyloid A is not shared by the endogenous protein in the circulation. Arthritis Rheum. 2010;62(6):1660\u20135.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1009_CR48","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/art.37737","volume":"65","author":"B van den Brand","year":"2013","unstructured":"van den Brand B, Waterborg C, van den Berg W, van de Loo F. Is the serum amyloid A we use really serum amyloid A? Comment on the article by Connolly et al. Arthritis Rheum. 2013;65(1):283\u20134.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"1009_CR49","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1186\/1475-2840-12-166","volume":"12","author":"PE Deetman","year":"2013","unstructured":"Deetman PE, Bakker SJ, Dullaart RP. High sensitive C-reactive protein and serum amyloid A are inversely related to serum bilirubin: effect-modification by metabolic syndrome. Cardiovasc Diabetol. 2013;12(1):166.","journal-title":"Cardiovasc Diabetol"},{"issue":"6","key":"1009_CR50","doi-asserted-by":"publisher","first-page":"825","DOI":"10.3899\/jrheum.121358","volume":"40","author":"A Jamnitski","year":"2013","unstructured":"Jamnitski A, Levels JH, van den Oever IA, Nurmohamed MT. High-density lipoprotein profiling changes in patients with rheumatoid arthritis treated with tumor necrosis factor inhibitors: a cohort study. J Rheumatol. 2013;40(6):825\u201330.","journal-title":"J Rheumatol"},{"issue":"3","key":"1009_CR51","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1111\/j.1365-2249.2010.04300.x","volume":"163","author":"E Hatanaka","year":"2011","unstructured":"Hatanaka E, Dermargos A, Armelin HA, Curi R, Campa A. Serum amyloid A induces reactive oxygen species (ROS) production and proliferation of fibroblast. Clin Exp Immunol. 2011;163(3):362\u20137.","journal-title":"Clin Exp Immunol"},{"issue":"7","key":"1009_CR52","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.1017\/S0007114514001639","volume":"112","author":"N Nadeem","year":"2014","unstructured":"Nadeem N, Woodside JV, Neville CE, McCall DO, McCance D, Edgar D, et al. Serum amyloid A-related inflammation is lowered by increased fruit and vegetable intake, while high-sensitive C-reactive protein, IL-6 and E-selectin remain unresponsive. Br J Nutr. 2014;112(7):1129\u201336.","journal-title":"Br J Nutr"}],"container-title":["Arthritis Research & Therapy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1009-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13075-016-1009-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1009-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13075-016-1009-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T13:39:30Z","timestamp":1589549970000},"score":1,"resource":{"primary":{"URL":"https:\/\/arthritis-research.biomedcentral.com\/articles\/10.1186\/s13075-016-1009-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,17]]},"references-count":52,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["1009"],"URL":"https:\/\/doi.org\/10.1186\/s13075-016-1009-y","relation":{},"ISSN":["1478-6362"],"issn-type":[{"value":"1478-6362","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,17]]},"assertion":[{"value":"16 January 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2016","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"108"}}